NCT05850507View on ClinicalTrials.gov

Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)

NACompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

March 17, 2023

Primary Completion Date

October 17, 2023

Study Completion Date

March 20, 2024

Conditions
Coronavirus
Interventions
BIOLOGICAL

Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)

Intramuscular injection of deltoid muscle of upper arm of 25μg/0.5ml/person dose Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells).

BIOLOGICAL

Recombinant novel coronavirus protein vaccine (CHO cells)

Intramuscular injection of deltoid muscle of upper arm of 25μg/0.5ml/person dose Recombinant new coronavirus vaccine (CHO cells) .

Trial Locations (1)

241001

Wannan Medical College Yijishan Hospital, Wuhu

All Listed Sponsors
lead

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

INDUSTRY